Key regions: China, Europe, Australia, United States, Germany
The Other Pharmaceuticals market in Cambodia has seen significant growth in recent years.
Customer preferences: Cambodian customers have shown a growing demand for Other Pharmaceuticals, which are drugs that are not classified as traditional Western medicine. This is due to a preference for more natural or traditional remedies, as well as a lack of access to Western medicine in some areas. Additionally, there is a growing interest in preventative healthcare, which has led to an increased demand for health supplements and vitamins.
Trends in the market: One of the key trends in the Other Pharmaceuticals market in Cambodia is the rise of local producers. Cambodian companies have been investing in research and development to create their own natural remedies and supplements, which has led to a wider variety of products available to consumers. Another trend is the increasing popularity of online sales, which has allowed for greater access to products for those living in rural areas.
Local special circumstances: Cambodia has a long tradition of natural medicine, which has contributed to the growth of the Other Pharmaceuticals market. Additionally, the country has a large rural population with limited access to Western medicine, which has created a need for alternative remedies. The government has also been supportive of the development of the local pharmaceutical industry, which has helped to drive growth.
Underlying macroeconomic factors: Cambodia's economy has been growing steadily in recent years, which has led to an increase in disposable income. This has allowed for greater spending on healthcare and wellness products, including Other Pharmaceuticals. Additionally, the country's young and growing population has contributed to the growth of the market, as younger consumers are more likely to be interested in preventative healthcare. Finally, the government's efforts to improve healthcare access and infrastructure have also contributed to the growth of the market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
